Samenvatting
Objective: To date, only a small number of epidemiological studies on myelofibrosis have been performed. The current study aimed to characterize the myelofibrosis patient population in Belgium according to pre-defined disease parameters (diagnosis, risk categories, hemoglobin 50.000/µl and 201 (80%) had platelet count >100.000/µl. Of 250 patients, 85 (34%) had a myeloblast count >1%. Six (2%) patients had undergone a splenectomy. Thirteen (5* 2%) patients had undergone radiotherapy for splenomegaly. Conclusions: The results of this survey provide insight into the characteristics of the Belgian myelofibrosis population. They also suggest that a large proportion of these patients could stand to benefit from the therapies currently under development.
Originele taal-2 | English |
---|---|
Pagina's (van-tot) | 105-111 |
Tijdschrift | Acta Clin Belg |
Volume | 70 |
Nummer van het tijdschrift | 2 |
Vroegere onlinedatum | 6 nov 2014 |
Status | Published - apr 2015 |